UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis

Cancer treatment reviews, 2017-04, Vol.55, p.10-15

2017

Volltextzugriff (PDF)

Carboplatin/ nab -Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 Results

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.236-236

2017

Volltextzugriff (PDF)

Dose-Related Effect of Statins in Venous Thrombosis Risk Reduction

Journal of vascular surgery, 2012, Vol.55 (2), p.614-615

2012

Volltextzugriff (PDF)

EP06.01-01 Concordance Between Generative AI GPT-4 and NCCN Guidelines: Biomarker-Driven Treatment Strategies in NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S477

2023

Volltextzugriff (PDF)

P2.11A.22 Higher Blood TMB/Tissue TMB Ratio as an Inferior Prognostic Biomarker for Survival in Advanced Stage NSCLC

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S262-S262

2024

Volltextzugriff (PDF)

MA09.13 Clinical Outcome of Bilateral Invasive Mucinous Adenocarcinoma(IMA) without Mediastinal Nodal Involvement from SEER Database

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S91-S92

2024

Volltextzugriff (PDF)

EP.06C.02 Clinical Features and Survival Outcome of Lung Invasive Mucinous Adenocarcinoma: A Real-World Analysis of 387,197 Patients

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S498-S499

2024

Volltextzugriff (PDF)

P16.01 Clonal Landscape Predicts Outcome in Lung Squamous Cell Carcinoma Patients with a Low Tumor Mutational Burden

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1015-S1015

2021

Volltextzugriff (PDF)

P2.19-02 [DREAM] Double Lung Transplant Registry Aimed for Lung-Limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S384-S385

2023

Volltextzugriff (PDF)

EP05.03-011 Bilateral Orthotopic Lung Transplantation for a Patient with Advanced Invasive Mucinous Adenocarcinoma

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S300-S301

2022

Volltextzugriff (PDF)

P2.12-04 The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S152-S153

2022

Volltextzugriff (PDF)

EP08.02-023 Differentiation Syndrome in a Patient with Non-Small-Cell Lung Cancer Harboring IDH2 Mutation Treated with Enasidenib

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S407-S408

2022

Volltextzugriff (PDF)

EP.09B.05 The Role of Pulmonary Metastasectomy (PM) For Non-Primary Lung Cancer: Umbrella Review of Meta-Analyses

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S594-S595

2024

Volltextzugriff (PDF)

P46.05 Durable Response to Double Dose Osimertinib 160mg in EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1095-S1095

2021

Volltextzugriff (PDF)

P2.31-07 Incidence and Survival Outcomes of Lung Cancer Post-Double Lung Transplant and its Association with Graft Rejection

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S409-S410

2023

Volltextzugriff (PDF)

P1.21-19 Potential Utilization of Serum Glycoproteomics as a Biomarker to Predict Survival Outcomes and irAEs in Advanced NSCLC Treated with ICI

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S242-S243

2023

Volltextzugriff (PDF)

P1.21-18 Potential Role of Serum Glycoproteomics in Predicting irAEs in NSCLC Patients Treated with Immunotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S242

2023

Volltextzugriff (PDF)

P2.14B.01 [DREAM] Double Lung Transplant Registry Aimed for Lung-limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S279-S279

2024

Volltextzugriff (PDF)

EP.11B.04 Differential Durable Responses in Intrathoracic Versus Overall Lesions of Non-Small Cell Lung Cancer Treated with Immunotherapy

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S611-S611

2024

Volltextzugriff (PDF)

EP16.02-022 Circulating Tumor DNA Minimal Residual Disease Assay Predicts Outcome in Lung Cancer Patients Who Had Curative Treatments

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S580-S581

2022

Volltextzugriff (PDF)

EP08.02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S410

2022

Volltextzugriff (PDF)

P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S623-S624

2019

Volltextzugriff (PDF)

P1.09B.02 Double Lung Transplantation in Patients with Metastatic Lung-limited Non-Small Cell Lung Carcinoma (NSCLC)

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S187-S187

2024

Volltextzugriff (PDF)

EP.03G.02 Molecular and Immune Landscape of Invasive Mucinous Adenocarcinoma (IMA) Of the Lung and Its Survival Outcome

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S457-S458

2024

Volltextzugriff (PDF)

255TiP [DREAM] Double lung transplant registry aimed for lung-limited malignancies: A prospective registry study for medically refractory cancers

ESMO open, 2024-03, Vol.9, p.102919, Article 102919

2024

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(149)

Publikationsform

Artikel
(160)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(41)
Physics
(21)
Physical Sciences
(19)
Humans
(17)
Biological And Medical Sciences
(14)
Animals
(10)
Biochemistry & Molecular Biology
(10)
Technology
(10)
Male
(9)
Agriculture
(8)
Female
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Medical Sciences
(8)
Physics, Nuclear
(8)
Agriculture, Dairy & Animal Science
(7)
Growth Performance
(7)
Microbiology
(7)
Middle Aged
(7)
Anabaena
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis

Carboplatin/ nab -Paclitaxel and Pembrolizumab for Patients with Advanced Non–Small Cell Lung Cancer (NSCLC): Phase 1 Results

Dose-Related Effect of Statins in Venous Thrombosis Risk Reduction

EP06.01-01 Concordance Between Generative AI GPT-4 and NCCN Guidelines: Biomarker-Driven Treatment Strategies in NSCLC

P2.11A.22 Higher Blood TMB/Tissue TMB Ratio as an Inferior Prognostic Biomarker for Survival in Advanced Stage NSCLC

MA09.13 Clinical Outcome of Bilateral Invasive Mucinous Adenocarcinoma(IMA) without Mediastinal Nodal Involvement from SEER Database

EP.06C.02 Clinical Features and Survival Outcome of Lung Invasive Mucinous Adenocarcinoma: A Real-World Analysis of 387,197 Patients

P16.01 Clonal Landscape Predicts Outcome in Lung Squamous Cell Carcinoma Patients with a Low Tumor Mutational Burden

P2.19-02 [DREAM] Double Lung Transplant Registry Aimed for Lung-Limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

EP05.03-011 Bilateral Orthotopic Lung Transplantation for a Patient with Advanced Invasive Mucinous Adenocarcinoma

P2.12-04 The Role of Serum Proteomic Signature in Predicting Survival in PD-L1 Low Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor (ICI)

EP08.02-023 Differentiation Syndrome in a Patient with Non-Small-Cell Lung Cancer Harboring IDH2 Mutation Treated with Enasidenib

EP.09B.05 The Role of Pulmonary Metastasectomy (PM) For Non-Primary Lung Cancer: Umbrella Review of Meta-Analyses

P46.05 Durable Response to Double Dose Osimertinib 160mg in EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases

P2.31-07 Incidence and Survival Outcomes of Lung Cancer Post-Double Lung Transplant and its Association with Graft Rejection

P1.21-19 Potential Utilization of Serum Glycoproteomics as a Biomarker to Predict Survival Outcomes and irAEs in Advanced NSCLC Treated with ICI

P1.21-18 Potential Role of Serum Glycoproteomics in Predicting irAEs in NSCLC Patients Treated with Immunotherapy

P2.14B.01 [DREAM] Double Lung Transplant Registry Aimed for Lung-limited Malignancies - A Prospective Registry Study for Medically Refractory Cancers

EP.11B.04 Differential Durable Responses in Intrathoracic Versus Overall Lesions of Non-Small Cell Lung Cancer Treated with Immunotherapy

EP16.02-022 Circulating Tumor DNA Minimal Residual Disease Assay Predicts Outcome in Lung Cancer Patients Who Had Curative Treatments

EP08.02-028 Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study

P1.17-40 Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment

P1.09B.02 Double Lung Transplantation in Patients with Metastatic Lung-limited Non-Small Cell Lung Carcinoma (NSCLC)

EP.03G.02 Molecular and Immune Landscape of Invasive Mucinous Adenocarcinoma (IMA) Of the Lung and Its Survival Outcome

255TiP [DREAM] Double lung transplant registry aimed for lung-limited malignancies: A prospective registry study for medically refractory cancers

Suchergebnisse filtern